After-Hours Gainers: A Quiet Session With A Standout Biotech Surge

The after-hours market delivered a mixed but generally positive tone on Tuesday evening, with several small- and mid-cap names posting modest gains. One biotech, however, stole the spotlight with a dramatic surge following major clinical news.DBV Technologies S.A. (DBVT) dominated the after-hours session, soaring 61.29% to $29.00, up $11.02, after announcing a pivotal clinical milestone. The company reported that VITESSE, its Phase 3 study evaluating the VIASKIN Peanut patch in peanut-allergic children age ...